Suturion Revenue

About Suturion

Problems that occur after open abdominal surgery are both painful and difficult for clincians and patients. Scientific evidence shows that the right surgical technique can reduce complications after open surgical procedures. Research shows that it is essential to follow best practice and clinical guidelines to reduce the risk of complications, such as incisional hernia and deep wound infections. We at Suturion want to be part of preventing these unnecessary complications by assisting clinicians with technologies to adhere to best practice prinicples of abdominal closure. During training and practice surgeon Gabriel Börner often encountered complications to closure of the abdomen after surgery. Most notably wound infections and incisional hernias. This experience, together with a growing body of scientific evidence and research showing that a evidence-based surgical technique can reduce these complications planted an idea that a device could help surgeons prevent hernias instead of repairing them. Suturion AB was founded in 2018 by Gabriel Börner and medtech engineer Mats O. Christensson and LU Holding AB. Suturion have during the last years filed several patent applications, performed extensive market analysis and pre-clinical research. Gabriel Börner MD is a frequent speaker at medical congresses and travels the world presenting his scientific research and findings. In 2024, Suturion has finalized a clinical trial which is an important step toward the regulatory pathway for CE and FDA approval.

View contact profiles from Suturion